Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 5/2019

05.09.2018 | Original Article

Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram

verfasst von: Yanwu Sun, Yiyi Zhang, Zhekun Huang, Pan Chi

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to investigate the prognostic significance of negative lymph nodes (NLNs) for ypN+ rectal cancer after neoadjuvant chemoradiotherapy (nCRT) and radical surgery and to construct a nomogram predicting disease-free survival (DFS).

Method

One hundred fifty-eight eligible patients were included. X-tile analysis was performed to determine cutoff values of NLNs. Clinicopathological and survival outcomes were compared. A Cox regression analysis was performed to identify prognostic factors of DFS. A nomogram was constructed and validated internally.

Results

X-tile analysis identified cutoff values of 4 and 16 in terms of DFS (χ2 = 8.129, p = 0.017). The 3-year DFS rates for low (≤ 4), middle (5–16), and high (≥ 17) NLNs group was 15.2, 55.5, and 73.1%, respectively (P = 0.017). NLN count (NLNs ≥ 17, HR = 0.400, P = 0.022), IMA nodal metastasis (HR = 1.944, P = 0.025), tumor differentiation (poor/anaplastic, HR = 1.805, P = 0.021), and ypT4 stage (HR = 7.787, P = 0.047) were independent prognostic factors of DFS. A predicting nomogram incorporating the four significant predictors was developed with a C-index of 0.64.

Conclusion

NLN count was an independent prognostic factor of DFS in patients with ypN+ rectal cancer following nCRT. A nomogram incorporating NLN count, IMA nodal metastasis, tumor differentiation, and ypT stage could stratify rectal cancer patients with different DFS and might be helpful during clinical decision-making.
Literatur
1.
Zurück zum Zitat Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009; 27: 5124–30.CrossRefPubMedPubMedCentral Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009; 27: 5124–30.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van de Velde CJ. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; 12: 575–82.CrossRefPubMed van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van de Velde CJ. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; 12: 575–82.CrossRefPubMed
3.
Zurück zum Zitat Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rodel C. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012; 39: 1926–33.CrossRef Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rodel C. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012; 39: 1926–33.CrossRef
4.
Zurück zum Zitat Glynne-Jones R. Neoadjuvant treatment in rectal cancer: do we always need radiotherapy-or can we risk assess locally advanced rectal cancer better? Recent Results Cancer Res. 2012; 196: 21–36.CrossRefPubMed Glynne-Jones R. Neoadjuvant treatment in rectal cancer: do we always need radiotherapy-or can we risk assess locally advanced rectal cancer better? Recent Results Cancer Res. 2012; 196: 21–36.CrossRefPubMed
5.
Zurück zum Zitat Schmoll H, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde C, Balmana J, Regula J, Nagtegaal I, Beets-Tan R, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne C, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard J, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012; 23: 2479–516.CrossRefPubMed Schmoll H, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde C, Balmana J, Regula J, Nagtegaal I, Beets-Tan R, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne C, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard J, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012; 23: 2479–516.CrossRefPubMed
6.
Zurück zum Zitat Leibold T, Shia J, Ruo L, Minsky B, Akhurst T, Gollub M, Ginsberg M, Larson S, Riedel E, Wong W, Guillem J. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol. 2008; 26: 2106–11.CrossRefPubMed Leibold T, Shia J, Ruo L, Minsky B, Akhurst T, Gollub M, Ginsberg M, Larson S, Riedel E, Wong W, Guillem J. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol. 2008; 26: 2106–11.CrossRefPubMed
7.
Zurück zum Zitat Okada K, Sadahiro S, Suzuki T, Tanaka A, Saito G, Kamijo A, Akiba T, Kawada S. Effects of chemoradiotherapy on lymph nodes in patients with rectal adenocarcinoma: evaluation of numbers and sizes of retrieved lymph nodes inside and outside the radiation field. Anticancer Res. 2014; 34: 4195–200.PubMed Okada K, Sadahiro S, Suzuki T, Tanaka A, Saito G, Kamijo A, Akiba T, Kawada S. Effects of chemoradiotherapy on lymph nodes in patients with rectal adenocarcinoma: evaluation of numbers and sizes of retrieved lymph nodes inside and outside the radiation field. Anticancer Res. 2014; 34: 4195–200.PubMed
8.
Zurück zum Zitat Amin M, Edge S, Greene F, Byrd D, Brookland R, Washington M, Gershenwald J, Compton C, Hess K, Sullivan D, Jessup J, Brierley J, Gaspar L, Schilsky R, Balch C, Winchester D, Asare E, Madera M, Gress D, Meyer L, AJCC Cancer Staging Manual. 8th ed ed. 2017, New York: Springer. 252–74.CrossRef Amin M, Edge S, Greene F, Byrd D, Brookland R, Washington M, Gershenwald J, Compton C, Hess K, Sullivan D, Jessup J, Brierley J, Gaspar L, Schilsky R, Balch C, Winchester D, Asare E, Madera M, Gress D, Meyer L, AJCC Cancer Staging Manual. 8th ed ed. 2017, New York: Springer. 252–74.CrossRef
9.
Zurück zum Zitat Willaert W, Mareel M, Van De Putte D, Van Nieuwenhove Y, Pattyn P, Ceelen W. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon. Cancer Treat Rev. 2014; 40: 405–13.CrossRefPubMed Willaert W, Mareel M, Van De Putte D, Van Nieuwenhove Y, Pattyn P, Ceelen W. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon. Cancer Treat Rev. 2014; 40: 405–13.CrossRefPubMed
10.
Zurück zum Zitat Damin D, Rosito M, Contu P, Tarta C, Ferreira P, Kliemann L, Schwartsmann G. Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer. J Gastrointest Surg. 2012; 16: 1573–80.CrossRefPubMed Damin D, Rosito M, Contu P, Tarta C, Ferreira P, Kliemann L, Schwartsmann G. Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer. J Gastrointest Surg. 2012; 16: 1573–80.CrossRefPubMed
11.
Zurück zum Zitat Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner G, Mino-Kenudson M, Giovannucci E, Meyerhardt J, Fuchs C. Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol. 2010; 105: 420–33.CrossRefPubMed Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner G, Mino-Kenudson M, Giovannucci E, Meyerhardt J, Fuchs C. Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol. 2010; 105: 420–33.CrossRefPubMed
12.
Zurück zum Zitat Wong J, Bowles B, Bueno R, Shimizu D. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon rectum. 2002; 45: 1341–8. Wong J, Bowles B, Bueno R, Shimizu D. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon rectum. 2002; 45: 1341–8.
13.
Zurück zum Zitat Deng J, Liang H, Wang D, Sun D, Ding X, Pan Y, Liu X. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol. 2010; 17: 1043–51.CrossRefPubMed Deng J, Liang H, Wang D, Sun D, Ding X, Pan Y, Liu X. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol. 2010; 17: 1043–51.CrossRefPubMed
14.
Zurück zum Zitat Zhu Z, Chen H, Yu W, Fu X, Xiang J, Li H, Zhang Y, Sun M, Wei Q, Zhao W, Zhao K. Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy. Ann Surg Oncol. 2014; 21: 2857–63.CrossRefPubMed Zhu Z, Chen H, Yu W, Fu X, Xiang J, Li H, Zhang Y, Sun M, Wei Q, Zhao W, Zhao K. Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy. Ann Surg Oncol. 2014; 21: 2857–63.CrossRefPubMed
15.
Zurück zum Zitat Chen Y, Zhang L, Tian J, Ren X, Hao Q. Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients. Cancer Cell Int. 2013; 13: 6.CrossRefPubMedPubMedCentral Chen Y, Zhang L, Tian J, Ren X, Hao Q. Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients. Cancer Cell Int. 2013; 13: 6.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Ryan R, Gibbons D, Hyland J, Treanor D, White A, Mulcahy H, O'Donoghue D, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005; 47: 141–6.CrossRefPubMed Ryan R, Gibbons D, Hyland J, Treanor D, White A, Mulcahy H, O'Donoghue D, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005; 47: 141–6.CrossRefPubMed
17.
Zurück zum Zitat Camp R, Dolled-Filhart M, Rimm D. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10: 7252–9.CrossRefPubMed Camp R, Dolled-Filhart M, Rimm D. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10: 7252–9.CrossRefPubMed
18.
Zurück zum Zitat Steyerberg E, Clinical prediction models: a practical approach to development, validation, and updating. 2009, New York, NY: Springer.CrossRef Steyerberg E, Clinical prediction models: a practical approach to development, validation, and updating. 2009, New York, NY: Springer.CrossRef
19.
Zurück zum Zitat Habr-Gama A, Perez R, Proscurshim I, Rawet V, Pereira D, Sousa A, Kiss D, Cecconello I. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon rectum. 2008; 51: 277–83. Habr-Gama A, Perez R, Proscurshim I, Rawet V, Pereira D, Sousa A, Kiss D, Cecconello I. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon rectum. 2008; 51: 277–83.
20.
Zurück zum Zitat Persiani R, Biondi A, Gambacorta M, Bertucci Zoccali M, Vecchio F, Tufo A, Coco C, Valentini V, Doglietto G, D'Ugo D. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer. Br J Surg. 2014; 101: 133–42.CrossRefPubMed Persiani R, Biondi A, Gambacorta M, Bertucci Zoccali M, Vecchio F, Tufo A, Coco C, Valentini V, Doglietto G, D'Ugo D. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer. Br J Surg. 2014; 101: 133–42.CrossRefPubMed
21.
Zurück zum Zitat Kim H, Jo J, Lee S, Kim C, Kim Y, Kim H. Low lymph node retrieval after preoperative chemoradiation for rectal cancer is associated with improved prognosis in patients with a good tumor response. Ann Surg Oncol. 2015; 22: 2075–81.CrossRefPubMed Kim H, Jo J, Lee S, Kim C, Kim Y, Kim H. Low lymph node retrieval after preoperative chemoradiation for rectal cancer is associated with improved prognosis in patients with a good tumor response. Ann Surg Oncol. 2015; 22: 2075–81.CrossRefPubMed
22.
Zurück zum Zitat Beresford M, Glynne-Jones R, Richman P, Makris A, Mawdsley S, Stott D, Harrison M, Osborne M, Ashford R, Grainger J, Al-Jabbour J, Talbot I, Mitchell I, Meyrick Thomas J, Livingstone J, McCue J, MacDonald P, Northover J, Windsor A, Novell R, Wallace M, Harrison R. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol (R Coll Radiol). 2005; 17: 448–55.CrossRefPubMed Beresford M, Glynne-Jones R, Richman P, Makris A, Mawdsley S, Stott D, Harrison M, Osborne M, Ashford R, Grainger J, Al-Jabbour J, Talbot I, Mitchell I, Meyrick Thomas J, Livingstone J, McCue J, MacDonald P, Northover J, Windsor A, Novell R, Wallace M, Harrison R. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol (R Coll Radiol). 2005; 17: 448–55.CrossRefPubMed
23.
Zurück zum Zitat Kim N, Kim Y, Min B, Le EK, Sohn S, Cho C. Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer. World J Surg. 2009; 33: 1741–9.CrossRefPubMed Kim N, Kim Y, Min B, Le EK, Sohn S, Cho C. Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer. World J Surg. 2009; 33: 1741–9.CrossRefPubMed
24.
Zurück zum Zitat Lee W, Lee S, Baek J, Lee W, Lee J, Kim N, Park Y. What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer. Radiat Oncol. 2013; 8: 202.CrossRefPubMedPubMedCentral Lee W, Lee S, Baek J, Lee W, Lee J, Kim N, Park Y. What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer. Radiat Oncol. 2013; 8: 202.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannée G, Bioulac-Sage P, Rullier E. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 2008; 32: 45–50.CrossRefPubMed Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannée G, Bioulac-Sage P, Rullier E. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 2008; 32: 45–50.CrossRefPubMed
26.
Zurück zum Zitat McDonald J, Renehan A, O'Dwyer S, Haboubi N. Lymph node harvest in colon and rectal cancer: Current considerations. World J Gastrointest Surg. 2012; 4: 9–19.CrossRefPubMedPubMedCentral McDonald J, Renehan A, O'Dwyer S, Haboubi N. Lymph node harvest in colon and rectal cancer: Current considerations. World J Gastrointest Surg. 2012; 4: 9–19.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Bhangu A, Kiran R, Brown G, Goldin R, Tekkis P. Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer. Tech Coloproctol. 2014; 18: 709–17.CrossRefPubMed Bhangu A, Kiran R, Brown G, Goldin R, Tekkis P. Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer. Tech Coloproctol. 2014; 18: 709–17.CrossRefPubMed
28.
Zurück zum Zitat Mogoantă S, Calotă F, Vasile I, Crafciuc A, Gherghinescu M, Sapalidis K, Ilie D, Ion D. Histological and immunohistochemical study on sentinel lymph node in colorectal cancer - values and limitations. Rom J Morphol Embryol. 2016; 57: 65–74.PubMed Mogoantă S, Calotă F, Vasile I, Crafciuc A, Gherghinescu M, Sapalidis K, Ilie D, Ion D. Histological and immunohistochemical study on sentinel lymph node in colorectal cancer - values and limitations. Rom J Morphol Embryol. 2016; 57: 65–74.PubMed
29.
Zurück zum Zitat Rahbari N, Bork U, Motschall E, Thorlund K, Büchler M, Koch M, Weitz J. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2012; 30: 60–70.CrossRefPubMed Rahbari N, Bork U, Motschall E, Thorlund K, Büchler M, Koch M, Weitz J. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2012; 30: 60–70.CrossRefPubMed
30.
Zurück zum Zitat George S, Primrose J, Talbot R, Smith J, Mullee M, Bailey D, du Boulay C, Jordan H, Wessex Colorectal Cancer Audit Working G. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer. 2006; 95: 841–7.CrossRefPubMedPubMedCentral George S, Primrose J, Talbot R, Smith J, Mullee M, Bailey D, du Boulay C, Jordan H, Wessex Colorectal Cancer Audit Working G. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer. 2006; 95: 841–7.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Johnson P, Porter G, Ricciardi R, Baxter N. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006; 24: 3570–675.CrossRefPubMed Johnson P, Porter G, Ricciardi R, Baxter N. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006; 24: 3570–675.CrossRefPubMed
32.
Zurück zum Zitat Popat S, Hubner R, Houlston R. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005; 23: 609–18.CrossRefPubMed Popat S, Hubner R, Houlston R. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005; 23: 609–18.CrossRefPubMed
33.
Zurück zum Zitat Morris M, Platell C, Iacopetta B. Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy. Clin Cancer Res. 2008; 14: 1413–7.CrossRefPubMed Morris M, Platell C, Iacopetta B. Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy. Clin Cancer Res. 2008; 14: 1413–7.CrossRefPubMed
34.
Zurück zum Zitat Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner G, Mino-Kenudson M, Giovannucci E, Meyerhardt J, Fuchs C. Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol. 2010; 105: 420–33.CrossRefPubMed Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner G, Mino-Kenudson M, Giovannucci E, Meyerhardt J, Fuchs C. Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol. 2010; 105: 420–33.CrossRefPubMed
35.
Zurück zum Zitat Kim J, Lee K, Yu C, Kim H, Kim J, Chang H, Kim J, Kim J, Kim T. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. Eur J Surg Oncol. 2004; 30: 271–9.CrossRefPubMed Kim J, Lee K, Yu C, Kim H, Kim J, Chang H, Kim J, Kim J, Kim T. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. Eur J Surg Oncol. 2004; 30: 271–9.CrossRefPubMed
36.
Zurück zum Zitat Chin C, Yeh C, Tang R, Changchien C, Huang W, Wang J. The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer. Int J Colorectal Dis. 2008; 23: 783–8.CrossRefPubMed Chin C, Yeh C, Tang R, Changchien C, Huang W, Wang J. The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer. Int J Colorectal Dis. 2008; 23: 783–8.CrossRefPubMed
37.
Zurück zum Zitat Sun Y, Chi P, Lin H, Lu X, Huang Y, Xu Z, Huang S, Wang X. Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact. Eur J Surg Oncol. 2017; 43: 85–91.CrossRefPubMed Sun Y, Chi P, Lin H, Lu X, Huang Y, Xu Z, Huang S, Wang X. Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact. Eur J Surg Oncol. 2017; 43: 85–91.CrossRefPubMed
38.
Zurück zum Zitat Qiu H, Wu B, Xiao Y, Lin G. Combination of differentiation and T stage can predict unresponsiveness to neoadjuvant therapy for rectal cancer. Colorectal Dis. 2011; 13: 1353–60.CrossRefPubMed Qiu H, Wu B, Xiao Y, Lin G. Combination of differentiation and T stage can predict unresponsiveness to neoadjuvant therapy for rectal cancer. Colorectal Dis. 2011; 13: 1353–60.CrossRefPubMed
39.
Zurück zum Zitat Reggiani Bonetti L, Lionti S, Domati F, Barresi V. Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery? World J Gastroenterol. 2017; 28: 1412–23.CrossRef Reggiani Bonetti L, Lionti S, Domati F, Barresi V. Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery? World J Gastroenterol. 2017; 28: 1412–23.CrossRef
40.
Zurück zum Zitat Cui J, Yang L, Guo L, Shao Y, Tan D. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy. Oncotarget. 2017; 8: 37845–54.PubMedPubMedCentral Cui J, Yang L, Guo L, Shao Y, Tan D. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy. Oncotarget. 2017; 8: 37845–54.PubMedPubMedCentral
41.
Zurück zum Zitat Gill A, Brunson A, Lara P J, Khatri V, Semrad T. Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study. Eur J Surg Oncol. 2015; 41: 647–52.CrossRefPubMedPubMedCentral Gill A, Brunson A, Lara P J, Khatri V, Semrad T. Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study. Eur J Surg Oncol. 2015; 41: 647–52.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat De Stefano A, Moretto R, Bucci L, Pepe S, Romano F, Cella A, Attademo L, Rosanova M, De Falco S, Fiore G, Raimondo L, De Placido S, Carlomagno C. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? Clin Colorectal Cancer. 2014; 13: 185–91.CrossRefPubMed De Stefano A, Moretto R, Bucci L, Pepe S, Romano F, Cella A, Attademo L, Rosanova M, De Falco S, Fiore G, Raimondo L, De Placido S, Carlomagno C. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? Clin Colorectal Cancer. 2014; 13: 185–91.CrossRefPubMed
43.
Zurück zum Zitat Pita-Fernández S, Alhayek-Aí M, González-Martín C, López-Calviño B, Seoane-Pillado T, Pértega-Díaz S. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2015; 26: 644–56.CrossRefPubMed Pita-Fernández S, Alhayek-Aí M, González-Martín C, López-Calviño B, Seoane-Pillado T, Pértega-Díaz S. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2015; 26: 644–56.CrossRefPubMed
Metadaten
Titel
Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram
verfasst von
Yanwu Sun
Yiyi Zhang
Zhekun Huang
Pan Chi
Publikationsdatum
05.09.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 5/2019
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3942-3

Weitere Artikel der Ausgabe 5/2019

Journal of Gastrointestinal Surgery 5/2019 Zur Ausgabe

Evidence-Based Current Surgical Practice

Endoscopic Management of Acute Biliopancreatic Disorders

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.